What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Slanix Paul Alex: large open-market buy of PMN
$8.5M open-market purchase by Slanix Paul Alex, Director at ProMIS Neurosciences Inc, filed February 6, 2026. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View PMN
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Big BuyPMN
$9.21-1.71% today
Slanix Paul Alex · Director at ProMIS Neurosciences Inc
$8.5M
Slanix Paul Alex bought $8.5M of PMN (ProMIS Neurosciences Inc).
Insider purchase
Transaction details
Slanix Paul Alex, a Director, reported a $8.5M open-market purchase equal to 8.6% of PMN's market cap.
Slanix Paul Alex (Director) bought 700,741 shares of PMN, ProMIS Neurosciences Inc, Healthcare ($99.1M market cap), at $12.13 per share on February 3, 2026 for a total of $8.5M (8.6% of the market cap).
Slanix Paul Alex
Director
Purchase value$8.5M
Shares purchased700,741
Price per share$12.13 per share
- % of market cap
- 8.6%
- Trade date
- February 3, 2026
- Filed
- February 6, 2026
- Filing delay
- 3 days
Permalink https://bluecollarpicks.com/insider-trading/PMN/buy/2068904
Market context
PMN market snapshot
Current price$9.21
1-day change-1.71%
Market cap$99.1M
SectorHealthcare
Next earningsNovember 10, 2026
$9.21
Current price$9.21
Analyst target$34.84 (+215.1%)
Last enriched October 7, 2026 at 7:32 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
Grant Officer | $0 | ||
Buy Director | $45.3K | ||
Buy Director | $48.8K | ||
Buy Director | $48K | ||
Buy Director | $21.9K | ||
Buy Director | $22.5K | ||
Buy Officer | $25K | ||
Grant Director | $50K | ||
Grant Director | $0 | ||
Grant Officer | $25K | ||
Grant Officer | $0 | ||
Grant CEO | $75K | ||
Grant CEO | $0 | ||
Grant Officer | $80K | ||
Grant Officer | $0 | ||
Grant Director | $37K | ||
Grant Director | $0 | ||
Buy 10% Owner | Not reported | ||
| This filing | Big Buy Director | $8.5M | |
Buy Director | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy Officer | $14.9K | ||
Buy Director | $14.6K | ||
$0
Grant Officer
$45.3K
Buy Director
$48.8K
Buy Director
$48K
Buy Director
$21.9K
Buy Director
$22.5K
Buy Director
$25K
Buy Officer
$50K
Grant Director
$0
Grant Director
$25K
Grant Officer
Grant Officer
$75K
Grant CEO
$0
Grant CEO
$80K
Grant Officer
$0
Grant Officer
$37K
Grant Director
Grant Director
Not reported
Buy 10% Owner
$8.5M
Big Buy Director
Not reported
Buy Director
Not reported
Buy 10% Owner
Not reported
Buy 10% Owner
$14.9K
Buy Officer
$14.6K
Buy Director
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.